Psychemedics Corp
PMDDelisted Dec 13, 2024- Industry
- Services-Medical Laboratories
- SEC CIK
- 0000806517
Psychemedics Corp was delisted on Dec 13, 2024; its insiders filed their last Form 4 on Dec 17, 2024; 21 institutions reported holding it in 13F filings for Q3 2024, worth $2.85M in total; no superinvestor held it.
13F holders, Q3 2023
Institutional positions in Psychemedics Corp as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- +4 vs. Q2 2023
- Shares held
- 1.43M
- +47.3K (+3.4%) vs. Q2 2023
- Total value
- $5.68M
- −$631.0K (−10.0%) vs. Q2 2023
- New holders
- 6
- 5 more added
- Sold out
- 2
- 9 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $441.7K |
| Q3 2025 | 1 | $582.4K |
| Q2 2025 | 1 | $618.3K |
| Q1 2025 | 1 | $643.2K |
| Q4 2024 | 3 | $708.7K |
| Q3 2024 | 21 | $2.85M |
| Q2 2024 | 26 | $2.87M |
| Q1 2024 | 22 | $3.54M |
| Q4 2023 | 23 | $3.82M |
| Q3 2023 | 25 | $5.68M |
| Q2 2023 | 21 | $6.32M |
| Q1 2023 | 20 | $7.34M |
| Q4 2022 | 22 | $6.93M |
| Q3 2022 | 23 | $9.54M |
| Q2 2022 | 21 | $9.55M |
| Q1 2022 | 25 | $11.0M |
| Q4 2021 | 25 | $11.4M |
| Q3 2021 | 28 | $13.9M |
| Q2 2021 | 28 | $12.4M |
| Q1 2021 | 31 | $11.5M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Psychemedics Corp; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Capital Advisors, Ltd. LLC | 60 | $0 | 0.00% | +60 | New |
| JPMorgan Chase & Co | 5 | $20 | 0.00% | +5 | New |
| Caldwell Sutter Capital, Inc. | 30 | $119 | 0.00% | −547−94.8% | Reduced |
| Wells Fargo & Company | 35 | $138 | 0.00% | +1+2.9% | Added |
| FMR LLC | 100 | $397 | 0.00% | 00.0% | Unchanged |
| Provenance Wealth Advisors, LLC | 772 | $3.06K | 0.00% | +772 | New |
| Your Advocates Ltd., LLP | 1,400 | $5.56K | 0.00% | +1,400 | New |
| Tower Research Capital LLC (TRC) | 1,737 | $6.90K | 0.00% | +861+98.3% | Added |
| Royal Bank of Canada | 2,134 | $9.00K | 0.00% | −11−0.5% | Reduced |
| Morgan Stanley | 4,500 | $17.9K | 0.00% | −12,042−72.8% | Reduced |
| Northern Trust Corp | 16,864 | $67.0K | 0.00% | −1,753−9.4% | Reduced |
| Santa Monica Partners LP | 20,000 | $79.0K | 0.06% | 00.0% | Unchanged |
| Citadel Advisors LLC | 20,438 | $81.1K | 0.00% | +20,438 | New |
| Crawford Investment Counsel Inc | 32,098 | $127.4K | 0.00% | −210,015−86.7% | Reduced |
| Geode Capital Management, LLC | 36,596 | $145.3K | 0.00% | +1,390+3.9% | Added |
| Dimensional Fund Advisors LP | 38,184 | $151.6K | 0.00% | −17,971−32.0% | Reduced |
| Wealth Effects LLC | 40,701 | $161.6K | 0.08% | −800−1.9% | Reduced |
| Wedbush Securities Inc | 42,414 | $168.0K | 0.01% | +8,257+24.2% | Added |
| Cannell Capital LLC | 74,794 | $296.9K | 0.07% | 00.0% | Unchanged |
| BlackRock Inc. | 77,381 | $307.2K | 0.00% | −399−0.5% | Reduced |
| Ancora Advisors, LLC | 78,373 | $311.1K | 0.01% | 00.0% | Unchanged |
| RBF Capital, LLC | 144,231 | $572.6K | 0.04% | 00.0% | Unchanged |
| Vanguard Group Inc | 251,151 | $997.1K | 0.00% | +3,713+1.5% | Added |
| Renaissance Technologies LLC | 273,663 | $1.09M | 0.00% | −4,300−1.5% | Reduced |
| 22NW, LP | 274,418 | $1.09M | 0.81% | +274,418 | New |
| State Street Corp | 0 | $0 | 0.00% | −16,162−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −47−100.0% | Sold out |